These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36066698)

  • 1. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
    de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
    Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson's disease?
    de Siqueira EA; Magalhães EP; de Menezes RRPPB; Sampaio TL; Lima DB; da Silva Martins C; Neves KRT; de Castro Brito GA; Martins AMC; de Barros Viana GS
    Neurosci Lett; 2023 Jan; 793():136997. PubMed ID: 36470505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
    Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
    J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model.
    Kataura T; Saiki S; Ishikawa KI; Akamatsu W; Sasazawa Y; Hattori N; Imoto M
    J Neurochem; 2020 Oct; 155(1):81-97. PubMed ID: 32128811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
    Cui Q; Li X; Zhu H
    Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
    Pan PK; Qiao LY; Wen XN
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson's disease].
    Xu Y; Meng X; Zhao WX; Liu DG; Zhu JG; Yao R; Yao JC; Zhang GM
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1927-1935. PubMed ID: 37282969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Vasudevan Sajini D; Thaggikuppe Krishnamurthy P; Chakkittukandiyil A; Mudavath RN
    Neurochem Res; 2024 Jun; 49(6):1577-1587. PubMed ID: 38276990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20C, a bibenzyl compound isolated from Gastrodia elata, protects PC12 cells against rotenone-induced apoptosis via activation of the Nrf2/ARE/HO-1 signaling pathway.
    Huang JY; Yuan YH; Yan JQ; Wang YN; Chu SF; Zhu CG; Guo QL; Shi JG; Chen NH
    Acta Pharmacol Sin; 2016 Jun; 37(6):731-40. PubMed ID: 27180985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Diacetylcurcumin Manganese Complex on Rotenone-Induced Oxidative Stress, Mitochondria Dysfunction, and Inflammation in the SH-SY5Y Parkinson's Disease Cell Model.
    Pirunkaset E; Boonyarat C; Maneenet J; Khamphukdee C; Daodee S; Monthakantirat O; Awale S; Kijjoa A; Chulikhit Y
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariin protects rotenone-induced neurotoxicity through induction of SIRT3.
    Zeng R; Wang X; Zhou Q; Fu X; Wu Q; Lu Y; Shi J; Klaunig JE; Zhou S
    Toxicol Appl Pharmacol; 2019 Sep; 379():114639. PubMed ID: 31251943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of Ginsenoside Re against neurotoxin‑induced Parkinson's disease models via induction of Nrf2.
    Qiao J; Zhao Y; Liu Y; Zhang S; Zhao W; Liu S; Liu M
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35543148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Supplements of
    Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
    Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincamine alleviates brain injury by attenuating neuroinflammation and oxidative damage in a mouse model of Parkinson's disease through the NF-κB and Nrf2/HO-1 signaling pathways.
    Wang P; Chen C; Shan M
    J Biochem Mol Toxicol; 2024 May; 38(5):e23714. PubMed ID: 38629493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.
    Zheng W; Han X; Han B; Li G; Gan J; Wang T; Xu B; He J; Du W; Cao X; Wang Z
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effect of Dioscin against Parkinson's Disease via Adjusting Dual-Specificity Phosphatase 6 (DUSP6)-Mediated Oxidative Stress.
    Mao Z; Gao M; Zhao X; Li L; Peng J
    Molecules; 2022 May; 27(10):. PubMed ID: 35630630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
    Wang L; Cai X; Shi M; Xue L; Kuang S; Xu R; Qi W; Li Y; Ma X; Zhang R; Hong F; Ye H; Chen L
    Eur J Med Chem; 2020 Aug; 199():112385. PubMed ID: 32402936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.